Clinical characteristics of patients with pityriasis rubra pilaris following SARS‐CoV‐2 vaccination
Author:
Affiliation:
1. Department of Dermatology Christian Hospital Unna Unna Germany
2. Department of Dermatology, Skin Cancer Center Ruhr‐University Bochum Bochum Germany
Publisher
Wiley
Subject
Infectious Diseases,Dermatology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.19046
Reference9 articles.
1. Pityriasis rubra pilaris following inactivated SARS‐CoV ‐2 vaccine ( CoronaVac )
2. Pityriasis rubra pilaris (type I) following administration of the BNT162b2 mRNA COVID ‐19 vaccine: Successful treatment with ustekinumab and acitretin
3. Pityriasis rubra pilaris following booster dose of mRNA (Pfizer– BioNTech ) COVID ‐19 vaccine
4. Ixekizumab successfully treated severe pityriasis rubra pilaris after COVID‐19 vaccination
5. First Onset of Pityriasis Rubra Pilaris following SARS-CoV-2 Booster Vaccination: Case Report and Review of the Literature
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Erythroderma Following Pfizer-BioNTech COVID-19 Vaccination in a Patient With Atopic Dermatitis: A Case Report;Cureus;2024-09-08
2. Pityriasis rubra pilaris after COVID-19 vaccination: successful treatment with ustekinumab;Anais Brasileiros de Dermatologia;2024-07
3. Pityriasis Rubra Pilaris: An Updated Review of Clinical Presentation, Etiopathogenesis, and Treatment Options;American Journal of Clinical Dermatology;2023-12-30
4. Comment on: ‘Clinical characteristics of patients with pityriasis rubra pilaris following SARS‐CoV‐2 vaccination’ by Gambichler;Journal of the European Academy of Dermatology and Venereology;2023-06-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3